DE69133355D1 - Transgene tiere, zellen und zelllinien daraus und deren verwendung - Google Patents

Transgene tiere, zellen und zelllinien daraus und deren verwendung

Info

Publication number
DE69133355D1
DE69133355D1 DE69133355T DE69133355T DE69133355D1 DE 69133355 D1 DE69133355 D1 DE 69133355D1 DE 69133355 T DE69133355 T DE 69133355T DE 69133355 T DE69133355 T DE 69133355T DE 69133355 D1 DE69133355 D1 DE 69133355D1
Authority
DE
Germany
Prior art keywords
sequence
cells
cell lines
differentiation
control
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69133355T
Other languages
English (en)
Other versions
DE69133355T2 (de
Inventor
Mark David Noble
Parmjit Singh Jat
Dimitris Kioussis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Ludwig Institute for Cancer Research New York
Original Assignee
Medical Research Council
Ludwig Institute for Cancer Research New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council, Ludwig Institute for Cancer Research New York filed Critical Medical Research Council
Publication of DE69133355D1 publication Critical patent/DE69133355D1/de
Application granted granted Critical
Publication of DE69133355T2 publication Critical patent/DE69133355T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/04Immortalised cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00Cells related to new breeds of animals
    • C12N2517/02Cells from transgenic animals

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Environmental Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Catching Or Destruction (AREA)
DE69133355T 1990-02-20 1991-02-20 Transgene tiere, zellen und zelllinien daraus und deren verwendung Expired - Lifetime DE69133355T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909003791A GB9003791D0 (en) 1990-02-20 1990-02-20 Transgenic animals,cell lines therefrom,and their use
PCT/GB1991/000262 WO1991013150A1 (en) 1990-02-20 1991-02-20 Transgenic animals, cells and cell lines therefrom, and their use

Publications (2)

Publication Number Publication Date
DE69133355D1 true DE69133355D1 (de) 2004-02-26
DE69133355T2 DE69133355T2 (de) 2004-10-21

Family

ID=10671295

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69133355T Expired - Lifetime DE69133355T2 (de) 1990-02-20 1991-02-20 Transgene tiere, zellen und zelllinien daraus und deren verwendung

Country Status (12)

Country Link
US (1) US5688692A (de)
EP (1) EP0516664B1 (de)
JP (1) JP3333902B2 (de)
AT (1) ATE258226T1 (de)
AU (2) AU660604B2 (de)
CA (1) CA2076345C (de)
DE (1) DE69133355T2 (de)
DK (1) DK0516664T3 (de)
ES (1) ES2213742T3 (de)
GB (1) GB9003791D0 (de)
IE (1) IE910572A1 (de)
WO (1) WO1991013150A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866759A (en) * 1991-02-20 1999-02-02 Ludwig Institute For Cancer Research Transgenic mice expressing TSSV40 large T antigen
US7361505B1 (en) * 1991-07-08 2008-04-22 Neurospheres Holdings Ltd. Multipotent neural stem cell compositions
US5489743A (en) * 1993-01-19 1996-02-06 Amgen Inc. Transgenic animal models for thrombocytopenia
US5700657A (en) * 1993-12-13 1997-12-23 Genzyme Corporation Vectors and vector systems including genes encoding tumor suppressor proteins and producer cells transformed thereby
US5833979A (en) * 1994-07-20 1998-11-10 Cytotherapeutics, Inc. Methods and compositions of growth control for cells encapsulated within bioartificial organs
US5935849A (en) * 1994-07-20 1999-08-10 Cytotherapeutics, Inc. Methods and compositions of growth control for cells encapsulated within bioartificial organs
AUPM710194A0 (en) * 1994-07-26 1994-08-18 Commonwealth Scientific And Industrial Research Organisation Virus vector
EP0804554A1 (de) * 1994-09-09 1997-11-05 ZymoGenetics, Inc. Herstellung von immortalisierten zellen
WO1996014400A1 (en) * 1994-11-08 1996-05-17 Bradley Michael John Stringer Human cell-lines
US6495364B2 (en) 1995-05-23 2002-12-17 Neurotech, S.A. Mx-1 conditionally immortalized cells
US5994619A (en) * 1996-04-01 1999-11-30 University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus Production of chimeric bovine or porcine animals using cultured inner cell mass cells
US5905042A (en) * 1996-04-01 1999-05-18 University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus Cultured inner cell mass cell lines derived from bovine or porcine embryos
GB9607953D0 (en) * 1996-04-17 1996-06-19 Univ Liverpool Transgenic rat
US6215041B1 (en) 1997-01-10 2001-04-10 University Of Mmassachusetts Cloning using donor nuclei from a non-quiesecent somatic cells
US6235969B1 (en) 1997-01-10 2001-05-22 University Of Massachusetts Cloning pigs using donor nuclei from non-quiescent differentiated cells
FR2761576B1 (fr) * 1997-04-04 2002-08-30 Inst Nat Sante Rech Med Animal transgenique non humain dans lequel l'expression du gene codant pour l'insuline est supprimee
AU8284198A (en) 1997-07-02 1999-01-25 Board Of Regents, The University Of Texas System P53 as a regulator of cell differentiation
US6235527B1 (en) * 1997-11-29 2001-05-22 University Of Utah Research Foundation Lineage restricted glial precursors from the central nervous system
WO2000068359A1 (en) * 1999-05-07 2000-11-16 University Of Utah Research Foundation Lineage-restricted precursor cells isolated from mouse neural tube and mouse embryonic stem cells
US6498285B1 (en) * 1997-08-06 2002-12-24 Alexion Pharmaceuticals, Inc. Methods for producing transgenic pigs by microinjecting a blastomere
US5968829A (en) * 1997-09-05 1999-10-19 Cytotherapeutics, Inc. Human CNS neural stem cells
CA2345442A1 (en) * 1998-10-02 2000-04-13 Ys New Technology Institute Inc. Established cells
JP4321936B2 (ja) * 2000-02-16 2009-08-26 独立行政法人科学技術振興機構 不死化血管周皮細胞株
US7420030B2 (en) 2000-09-08 2008-09-02 The Board Of Regents Of The University Of Texas System Aminopeptidase A (APA) targeting peptides for the treatment of cancer
US20040170955A1 (en) * 2000-09-08 2004-09-02 Wadih Arap Human and mouse targeting peptides identified by phage display
US20050074747A1 (en) * 2000-09-08 2005-04-07 Wadih Arap Biopanning and rapid analysis of selective interactive ligands (brasil)
US7452964B2 (en) 2001-09-07 2008-11-18 Board Of Regents, The University Of Texas System Compositions and methods of use of targeting peptides against placenta and adipose tissues
WO2003007979A1 (en) * 2001-07-18 2003-01-30 Board Of Regents, The University Of Texas System An anti-angiogenic state in mice and humans with retinal photorecptor cell degeneration
US7671010B2 (en) * 2002-08-30 2010-03-02 The Board Of Regents Of The University Of Texas System Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
US20040048243A1 (en) * 2001-09-07 2004-03-11 Wadih Arap Methods and compositions for in vitro targeting
US8507445B2 (en) * 2001-09-07 2013-08-13 Board Of Regents, The University Of Texas System Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
GB2387599B (en) * 2002-04-17 2005-08-10 Jason Peter Brown Methods for producing antibodies
AU2004231094A1 (en) * 2003-04-14 2004-10-28 Board Of Regents, The University Of Texas System Methods for ex vivo hybridoma-free production of polyclonal and monoclonal antibodies and generation of immortalized cell populations
DK1758986T3 (en) 2004-06-09 2016-01-18 Univ Edinburgh Neural stem cells
US20100158878A1 (en) 2008-12-23 2010-06-24 Alexandra Capela Target populations of oligodendrocyte precursor cells and methods of making and using same
US11168369B2 (en) 2014-11-25 2021-11-09 The Brigham And Women's Hospital, Inc. Method of identifying and treating a person having a predisposition to or afflicted with a cardiometabolic disease
WO2016085876A1 (en) 2014-11-25 2016-06-02 The Broad Institute Inc. Clonal haematopoiesis
CN116590345B (zh) * 2023-05-06 2024-01-30 北京中医药大学 永生化小鼠足细胞系及其制备方法、分化方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870009A (en) * 1982-11-22 1989-09-26 The Salk Institute For Biological Studies Method of obtaining gene product through the generation of transgenic animals
US5087571A (en) * 1984-06-22 1992-02-11 President And Fellows Of Harvard College Method for providing a cell culture from a transgenic non-human mammal
US4736866A (en) * 1984-06-22 1988-04-12 President And Fellows Of Harvard College Transgenic non-human mammals
FR2596414B1 (fr) * 1986-03-28 1989-10-06 Pasteur Institut Hybridomes obtenus a partir de lymphocytes d'animaux transgeniques portant un gene exprimant une proteine donnee et procede de preparation d'une telle proteine a partir de tels hybridomes
DE3752347T2 (de) * 1986-05-20 2002-09-26 Gen Hospital Corp Verfahren zur pharmakokinetischen Studie der Insulin-Expression mit nicht-menschlichem Transgen-Säugetier
ES2038602T3 (es) * 1986-10-15 1993-08-01 Battelle Memorial Institute Metodo para la produccion de proteinas por medio de sistemas de expresion inducible en celulas-huesped en carioticas geneticamente modificadas multiplicadas in-vivo.
DE3854823T2 (de) * 1987-05-01 1996-05-23 Stratagene Inc Mutagenesetest durch Verwendung von nicht menschlichen Lebewesen, die Test-DNS-Sequenzen enthalten
FR2637613B1 (fr) * 1987-06-19 1991-09-27 Transgene Sa Procede de preparation de lignees cellulaires stables pour la production de proteines determinees, a partir d'animaux transgeniques; lignees cellulaires tumorales et proteines obtenues
WO1989005864A1 (en) * 1987-12-15 1989-06-29 The Trustees Of Princeton University Transgenic testing systems for mutagens and carcinogens
US5270191A (en) * 1988-04-12 1993-12-14 Massachusetts Institute Of Technology Method for manipulation of the cell types of eukaryotes
JPH03504799A (ja) * 1988-04-12 1991-10-24 マサチューセッツ・インスティチュート・オブ・テクノロジー 真核細胞の細胞型を操作する方法
EP0351921A3 (de) * 1988-07-22 1991-07-17 Merck & Co. Inc. Modifizierter beta-adrenergischer Rezeptor
AU650616B2 (en) * 1988-09-21 1994-06-30 Animal Biotechnology Cambridge Limited Derivation of pluripotential embryonic cell lines from domestic animals
GB8823869D0 (en) * 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
FR2649721B1 (fr) * 1989-07-13 1994-07-08 Univ Paris Construction immortalisante pour l'immortalisation cellulaire conditionnelle

Also Published As

Publication number Publication date
AU3305395A (en) 1996-01-11
ATE258226T1 (de) 2004-02-15
GB9003791D0 (en) 1990-04-18
ES2213742T3 (es) 2004-09-01
WO1991013150A1 (en) 1991-09-05
EP0516664B1 (de) 2004-01-21
AU7328691A (en) 1991-09-18
DK0516664T3 (da) 2004-05-24
CA2076345A1 (en) 1991-08-21
EP0516664A1 (de) 1992-12-09
DE69133355T2 (de) 2004-10-21
US5688692A (en) 1997-11-18
JP3333902B2 (ja) 2002-10-15
IE910572A1 (en) 1991-08-28
AU676118B2 (en) 1997-02-27
AU660604B2 (en) 1995-07-06
JPH05504066A (ja) 1993-07-01
CA2076345C (en) 2006-11-28

Similar Documents

Publication Publication Date Title
ATE258226T1 (de) Transgene tiere, zellen und zelllinien daraus und deren verwendung
Schwenk et al. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells.
Madison et al. Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine
Nottoli et al. AP-2-null cells disrupt morphogenesis of the eye, face, and limbs in chimeric mice
Lee et al. Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators
Jonsson et al. Insulin-promoter-factor 1 is required for pancreas development in mice
Pfeifer et al. The structural H19 gene is required for transgene imprinting
Jia et al. DAF-9, a cytochrome P450 regulating C. elegans larval development and adult longevity
Guo et al. A Cre recombinase transgene with mosaic, widespread tamoxifen‐inducible action
EP0591219A4 (en) Expression of active human protein c in mammary tissue of transgenic animals
ATE288484T1 (de) Transgene nicht-menschliche tiere ohne prionprotein
Sarao et al. Conditional transgene expression in endothelial cells
Sasaoka et al. Analysis of the human tyrosine hydroxylase promoter-chloramphenicol acetyltransferase chimeric gene expression in transgenic mice
Cao et al. Regulated cutaneous gene delivery: the skin as a bioreactor
Roubertoux et al. Differences between CBA/H and NZB mice on intermale aggression. II. Maternal effects
Zemen et al. Generation of Kcnma1fl‐tdTomato, a conditional deletion of the BK channel α subunit in mouse
Felmer et al. Inducible ablation of adipocytes in adult transgenic mice expressing the E. coli nitroreductase gene
ES2146235T3 (es) Celulas endoteliales transformadas.
Saito et al. ICSAT overexpression is not sufficient to cause adult T-cell leukemia or multiple myeloma
Jerecic et al. Studies on conditional gene expression in the brain
Yin et al. Development of a pituitary‐specific cre line targeted to the Pit‐1 lineage
BR0317765A (pt) Promotor artificial, fragmento de dna de um promotor artificial, cassete, vetor de dna, célula bacteriana, célula vegetal, planta transgência, descendência de plantas, e, purificação e utilização de uma proteìna recombinante
US7579515B2 (en) Increasing gamete production with a gene switch
Govind et al. Experimental induction of claw transformation in snapping shrimps
DE69832883D1 (de) Transgene schweine

Legal Events

Date Code Title Description
8364 No opposition during term of opposition